Anniina Jaaskelainen

Oulu, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.

Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.

Journal: Breast cancer research : BCR

Published: October 21, 2023

How breast cancer recurrences are found - a real-world, prospective cohort study.

How breast cancer recurrences are found - a real-world, prospective cohort study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 06, 2022

Real-world, single-centre prospective data of age at breast cancer onset: focus on survival and reproductive history.

Real-world, single-centre prospective data of age at breast cancer onset: focus on survival and reproductive history.

Journal: BMJ open

Published: February 01, 2021

Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital.

Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital.

Journal: BMJ open

Published: October 13, 2020

Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses.

Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 13, 2020

High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study.

High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study.

Journal: Frontiers in oncology

Published: February 29, 2020

Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer.

Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer.

Journal: Anticancer research

Published: August 27, 2019

Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer.

Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: May 25, 2019

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer.

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer.

Journal: BMC cancer

Published: April 20, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026